Member Info for Jet7

Helen Mahy (Chairman) was bullish about the prospects of TRIG this year and it seems rightly so with energy prices rising and the share price also doing nicely presently. I am now looking forward to seeing the proposed dividend rise next year, the fact that there was no increase in the company’s dividend this year I’m hoping and expecting a decent rise I also see more value medium/long term with these rising in price.

To the contrary, Liam and all his posts make me laugh, obviously for some COMPLETELY unknown reason Liam has issues with Futura or JB., He makes me realise what a happy life I have, no issues , no grievance , is what it is.

Anyway, all in place, only last week JB stated he expects there to be no further dilutions I believe, American trial on schedule, just a matter of waiting for news.

Anyway , Liam please keep printing your outdated data and we can wait and see who’s correct.

Hilarious!!!!!! Oh he’s shared his concerns with JB alright.

This really backs up the bullish demeanour of the board, Ken is very confident in the efficacy of Med lasting, saying that if anything efficacy improved during the European 3 months trial.

A new director to replace Jonathan Freeman shortly, let’s hope this is someone of standing within the pharma industry. A crucial period upcoming, as I said the market will not tolerate anymore second rate mistakes. It is obvious that the board have taken time and chosen partners with care., all now seems in place. Next 18 months should hopefully be exciting and rewarding, trust me all LTH deserve it!

The company have made too many blunders in the past, looking at everything you can now see a steely determination to make sure everything is in place. Now well funded and putting together a string of partners for various regions, they for sure have learnt from past mistakes. When Med 3000 passes the FDA trial you can be sure of fireworks regarding the share price. No more mistakes from James & Ken please , then we will all be celebrating.

LIAMBOOTH, I believe you are once again misleading the share chat, if Lombard started to sell their equity in Futura in any quantity it would decimate the share price. This would not make good business sense, therefore I would suggest to the contrary, perhaps Lombard suspect good things are coming. Yes on top of their present stake they still retain the warrants. I completely believe the opposite to you, however you look at it , Lombard buying more is definitely good news.

Haven’t heard anything from you regarding CSD lately, any updates please?

I believe you are wrong LIAMBOOTH, Angela replaced Derek Martin so the board is now different, were YOU not aware of this, where have you been? Get your facts correct please! Embarrassing.

https://www.google.co.uk/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwiru8HgoLDwAhVBXRUIHWXACIcQFjAMegQIAhAD&url=https%3A%2F%2Fwww.investegate.co.uk%2FNews%2Ffutura-medical-appoints-angela-hildreth-as-finance-director-after-derek-martin-resigns%2F793477%2F&usg=AOvVaw1dLe3hiJ9d6082cCXu53Eb

They are getting close, are you nervous? I can see some jaws hitting the floor!

Well said Italian, a balanced view, not all this delving back years to finding completely obscure writings on the subject of ED. Liambooth, ALL you print is biased, i might be able to understand but unfortunately I wasn’t a fly on the wall, I would so loved to have been! Cannot imagine what went on and was said.

Anyway on another note, I was at my golf club yesterday and casually mentioned that I was invested in FUM with an ED product coming to market. Out of the other 7 guys sitting at the table, 6 had heard of the product with the conversation then lasting the next 20 minutes on the subject and I can tell you it was joyous for them.

This is going to spread like wild fire, if this product has any impact treating ED it’s going to be massive, plus I honestly don’t believe it will take much marketing, it will do it by itself!

Enough is enough, time to move on my friend, get a life!

I always attend the AGM , but now there’s COVID which conveniently everyone uses to hide behind.

D, that is the same as what you have been writing all day long here, history, this product is new, if indeed the results were correct and it was having positive results with 60% of patients including severe that is quite remarkable! Just as Ralph says, I am sure these other products you mention do not have the same results.

You did not answer my question on Ken, he certainly comes over very positive in the sugar coated interviews on Proactive, but without being challenged on the subject. What is your opinions on what Ken says since Feb 20 until today?

There is one thing the company has got wrong, and Barder particularly, they simply avoid contact with shareholders, they do not issue all details freely. They definitely have got this wrong avoiding any questions/interrogation.

Look forward to your reply on Ken!

Liam booth or D, there seems to be an air of concern in this last post and the £30m spent by FUM May fade into insignificance if this gel is the real deal, you and your Merry men are certainly on a roll lately that’s for sure!

One question, not much mentioned about Ken, are you saying he is leading us down the garden path hand in hand with James?

Bucolic, Thanks for the reply, regarding the 20 black Africans, it is very apparent from Ken’s interview that the doctor/professor who is top in his field has taken great interest in this process even going to meet the FDA on one occasion. I am sure he will be well aware and selecting the correct candidates personally. Ken seemed to indicate this in his interview. The other 80 Eastern European’s I’m sure will have similar results as the 2019 trial.

Yes any issues can crop up, who knows, but as I said on Sunday this is now very much de-risked since European approval, it really does look to me that lessons have been learnt from past experiences. Now it’s all about partnerships and what is written in the detail of contracts. Futura have had hard lessons from partners sitting on products , that simply cannot happen this time, surely contracts will only be signed if previous bad experiences are dealt with in the contracts.
Ball in Futura’s court, bring it on. A game changing product!

Bucolic, good to see you are still holding, that says a lot. I am posting two interviews with Ken from end of 19 and beginning of 20. I feel that all aspects which are doubted are covered in these. Just as a matter of interest Bucolic, what are your reservations going forward that make you feel this has so much risk when you also consider where we stand today with the CE mark soon to be Issued.

https://www.proactiveinvestors.co.uk/companies/news/908950/futura-medical-sees--potentially-quicker-route-to-market--for-its-erectile-dysfunction-formulation-908950.html

https://www.proactiveinvestors.co.uk/companies/news/912877/futura-medical-kicks-off-process-for-its-ed-gel-to-be-approved-as-medical-device-912877.html

The hard work is done, the share price reflects where Futura now stands since news broke, I have been sceptical about the quality of Med3000 , but with the CE mark now almost in place those doubts have faded. The outlook for an OTC product like this are truly undervalued in my eyes, I cannot believe there is going to be any male out there who is not going to want to have a dob of this gel to try out even if it’s not required.

There is one thing left now in order to propel the share price into many £s and that is the quality of partners signed up around the world and any clauses within the contracts signed in selling the product. Futura have the benefit of having had CSD (for what ever reason never making it, even although from what I read there were positive reviews plus TPR which still today sits dormant, nowhere to be seen.) Futura now have on board companies aiding them with negotiating the deals and with the knowledge and experience of past failures you’d like to believe there are no excuses in not signing EXACTLY the right deals. The ball lays very much in Futura’s court today, it is absolutely crucial that these deals are not rushed into and the intricate details of them is scrutinised before signing. As I said , they appear to have everything in place for this to happen and with previous experiences there can surely be no excuses this time.

The only thing that is going to restrain the share price going forward/rocketing with all the news coming through in months to come is if Lombard start selling. They made a pile leading up to results at end of 2019 by off loading. Now with around 20% , will they do the same again, let’s hope not.

idg, Exactly my stance on FUM, can only be going one way in the medium/long term. The question is by how much and I would suggest certainly multiples of where it stands now. An absolute no brainer, buy hold , has to literally be a case of printing money.

I’ve studied the results, what are you referring too? Plus with this news are you really trying to tell me there is a spanner in the works?